Stay updated on Eucrisa for Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Eucrisa for Atopic Dermatitis Clinical Trial page.

Latest updates to the Eucrisa for Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the Eucrisa atopic dermatitis study is now displayed, with details on its completed status, participant criteria, intervention groups, and adherence outcomes, instead of a 403 error.SummaryDifference45%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check33 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the study record content. The detailed study-related sections and documents have been removed from the page.SummaryDifference18%

Stay in the know with updates to Eucrisa for Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eucrisa for Atopic Dermatitis Clinical Trial page.